Your browser doesn't support javascript.
loading
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Zimmermann, Heiner; Nitsche, Mirko; Pott, Christiane; Reinke, Petra; Babel, Nina; Hermann, Robert M; Hauser, Ingeborg A; Hahn, Dennis; Ritgen, Matthias; Pietschmann, Claudia; Klapper, Wolfram; Anagnostopoulos, Ioannis; Trappe, Ralf U.
Affiliation
  • Zimmermann H; Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Gröpelinger Heerstr. 406-408, 28239, Bremen, Germany.
  • Nitsche M; Center of Radiotherapy, Bremen, Germany.
  • Pott C; Department of Internal Medicine II: Haematology and Oncology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Reinke P; Department of Nephrology and Intensive Care, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Babel N; Center for Translational Medicine and Department of Internal Medicine I, Marien Hospital Herne, Ruhr-University Bochum University Hospital, Herne, Germany.
  • Hermann RM; Center of Radiotherapy, Bremen, Germany.
  • Hauser IA; Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.
  • Hahn D; Department of Nephrology, UKF, Goethe University Frankfurt, Frankfurt/Main, Germany.
  • Ritgen M; Department of Haematology, Oncology and Palliative Care, Katharinen hospital, Stuttgart, Germany.
  • Pietschmann C; Department of Internal Medicine II: Haematology and Oncology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Klapper W; Radiologie Bremen, Bremen, Germany.
  • Anagnostopoulos I; Department of Haematopathology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Trappe RU; Department of Pathology, University of Würzburg, Würzburg, Germany.
Ann Hematol ; 100(8): 2043-2050, 2021 Aug.
Article in En | MEDLINE | ID: mdl-33973053
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Diseases / Organ Transplantation / Rituximab / Antineoplastic Agents, Immunological / Immunosuppressive Agents / Lymphoproliferative Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Germany Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Diseases / Organ Transplantation / Rituximab / Antineoplastic Agents, Immunological / Immunosuppressive Agents / Lymphoproliferative Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Germany Country of publication: Germany